Trump unveils deal to expand coverage and lower costs on obesity drugs
Associated Press
1 / 4
President Donald Trump, left, shakes the hand of Novo Nordisk President and CEO Mike Doustdar during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci)President Donald Trump speaks during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci)President Donald Trump speaks as Heidi Overton, deputy director of the White House Domestic Policy Council, from left, David Moore, president of Novo Nordisk Inc., Novo Nordisk President and CEO Mike Doustdar, Eli Lilly CEO David Ricks, Chris Klomp, director of the Centers for Medicare and Medicaid Services, Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, and Health and Human Services Secretary Robert F. Kennedy Jr. listen during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci)FILE - Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California, May 8, 2025. (AP Photo/JoNel Aleccia, File)
Copyright 2025 The Associated Press. All rights reserved
President Donald Trump, left, shakes the hand of Novo Nordisk President and CEO Mike Doustdar during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci)
